These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38814532)

  • 1. Video-Based Kinematic Analysis of Movement Quality in a Phase 3 Clinical Trial of Troriluzole in Adults with Spinocerebellar Ataxia: A Post Hoc Analysis.
    L'Italien GJ; Oikonomou EK; Khera R; Potashman MH; Beiner MW; Maclaine GDH; Schmahmann JD; Perlman S; Coric V
    Neurol Ther; 2024 Aug; 13(4):1287-1301. PubMed ID: 38814532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychometric Validation of the Modified Functional Scale for the Assessment and Rating of Ataxia (f-SARA) in Patients With Spinocerebellar Ataxia.
    Potashman M; Popoff E; Powell L; Mackenzie A; Beiner MW; Coric V; Schmahmann J; L'Italien G
    Cerebellum; 2024 Oct; 23(5):2095-2108. PubMed ID: 38865059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gait characteristics and clinical relevance of hereditary spinocerebellar ataxia on deep learning.
    Jin L; Lv W; Han G; Ni L; Sun D; Hu X; Cai H
    Artif Intell Med; 2020 Mar; 103():101794. PubMed ID: 32143799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and Validation of SCACOMS, a Composite Scale for Assessing Disease Progression and Treatment Effects in Spinocerebellar Ataxia.
    L'Italien G; Popoff E; Rogula B; Powell L; Potashman M; Dickson S; O'Keefe P; Beiner M; Coric V; Perlman S; Schmahmann JD; Hendrix S
    Cerebellum; 2024 Oct; 23(5):2028-2041. PubMed ID: 38710966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of gait and balance impairment in people with spinocerebellar ataxia using wearable sensors.
    Zhou H; Nguyen H; Enriquez A; Morsy L; Curtis M; Piser T; Kenney C; Stephen CD; Gupta AS; Schmahmann JD; Vaziri A
    Neurol Sci; 2022 Apr; 43(4):2589-2599. PubMed ID: 34664180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Planning future clinical trials in Machado Joseph disease: Lessons from a phase 2 trial.
    Saute JA; Rieder CR; Castilhos RM; Monte TL; Schumacher-Schuh AF; Donis KC; D'Ávila R; Souza GN; Russo AD; Furtado GV; Gheno TC; Souza DO; Saraiva-Pereira ML; Portela LV; Camey S; Torman VB; Jardim LB
    J Neurol Sci; 2015 Nov; 358(1-2):72-6. PubMed ID: 26297649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erratum.
    Mult Scler; 2016 Oct; 22(12):NP9-NP11. PubMed ID: 26041800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gait Variability in Spinocerebellar Ataxia Assessed Using Wearable Inertial Sensors.
    Shah VV; Rodriguez-Labrada R; Horak FB; McNames J; Casey H; Hansson Floyd K; El-Gohary M; Schmahmann JD; Rosenthal LS; Perlman S; Velázquez-Pérez L; Gomez CM
    Mov Disord; 2021 Dec; 36(12):2922-2931. PubMed ID: 34424581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary Study of Vibrotactile Feedback during Home-Based Balance and Coordination Training in Individuals with Cerebellar Ataxia.
    Jabri S; Bushart DD; Kinnaird C; Bao T; Bu A; Shakkottai VG; Sienko KH
    Sensors (Basel); 2022 May; 22(9):. PubMed ID: 35591203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2D Gait Skeleton Data Normalization for Quantitative Assessment of Movement Disorders from Freehand Single Camera Video Recordings.
    Tang W; van Ooijen PMA; Sival DA; Maurits NM
    Sensors (Basel); 2022 Jun; 22(11):. PubMed ID: 35684866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Digital Gait Measures Capture 1-Year Progression in Early-Stage Spinocerebellar Ataxia Type 2.
    Seemann J; Daghsen L; Cazier M; Lamy JC; Welter ML; Giese MA; Synofzik M; Durr A; Ilg W; Coarelli G
    Mov Disord; 2024 May; 39(5):788-797. PubMed ID: 38419144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of riluzole in spinocerebellar ataxia type 2 in France (ATRIL): a multicentre, randomised, double-blind, placebo-controlled trial.
    Coarelli G; Heinzmann A; Ewenczyk C; Fischer C; Chupin M; Monin ML; Hurmic H; Calvas F; Calvas P; Goizet C; Thobois S; Anheim M; Nguyen K; Devos D; Verny C; Ricigliano VAG; Mangin JF; Brice A; Tezenas du Montcel S; Durr A
    Lancet Neurol; 2022 Mar; 21(3):225-233. PubMed ID: 35063116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized trial of varenicline (Chantix) for the treatment of spinocerebellar ataxia type 3.
    Zesiewicz TA; Greenstein PE; Sullivan KL; Wecker L; Miller A; Jahan I; Chen R; Perlman SL
    Neurology; 2012 Feb; 78(8):545-50. PubMed ID: 22323747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repetitive Transcranial Magnetic Stimulation in Spinocerebellar Ataxia: A Pilot Randomized Controlled Trial.
    Manor B; Greenstein PE; Davila-Perez P; Wakefield S; Zhou J; Pascual-Leone A
    Front Neurol; 2019; 10():73. PubMed ID: 30809184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of acetyl-DL-leucine on cerebellar ataxia (ALCAT trial): study protocol for a multicenter, multinational, randomized, double-blind, placebo-controlled, crossover phase III trial.
    Feil K; Adrion C; Teufel J; Bösch S; Claassen J; Giordano I; Hengel H; Jacobi H; Klockgether T; Klopstock T; Nachbauer W; Schöls L; Stendel C; Uslar E; van de Warrenburg B; Berger I; Naumann I; Bayer O; Müller HH; Mansmann U; Strupp M
    BMC Neurol; 2017 Jan; 17(1):7. PubMed ID: 28068987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anteroposterior Stability: A Determinant of Gait Dysfunction and Falls in Spinocerebellar Ataxia.
    Ganapathy VS; James TT; Philip M; Kamble N; Bhattacharya A; Dhargave P; Pal PK
    Ann Indian Acad Neurol; 2021; 24(4):518-523. PubMed ID: 34728944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase Ib dose-escalation study of troriluzole (BHV-4157), an oral glutamatergic signaling modulator, in combination with nivolumab in patients with advanced solid tumors.
    Silk AW; Saraiya B; Groisberg R; Chan N; Spencer K; Girda E; Shih W; Palmeri M; Saunders T; Berman RM; Coric V; Chen S; Zloza A; Vieth J; Mehnert JM; Malhotra J
    Eur J Med Res; 2022 Jul; 27(1):107. PubMed ID: 35780243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Individual changes in preclinical spinocerebellar ataxia identified via increased motor complexity.
    Ilg W; Fleszar Z; Schatton C; Hengel H; Harmuth F; Bauer P; Timmann D; Giese M; Schöls L; Synofzik M
    Mov Disord; 2016 Dec; 31(12):1891-1900. PubMed ID: 27782309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Digital Measures of Postural Sway Quantify Balance Deficits in Spinocerebellar Ataxia.
    Shah VV; Muzyka D; Jagodinsky A; McNames J; Casey H; El-Gohary M; Sowalsky K; Safarpour D; Carlson-Kuhta P; Schmahmann JD; Rosenthal LS; Perlman S; Horak FB; Gomez CM
    Mov Disord; 2024 Apr; 39(4):663-673. PubMed ID: 38357985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.